Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia

NCT07344948 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Schizophrenia Diagnosis

Interventions

DRUG: NTX-253
DRUG: Placebo

Sponsor

Neurosterix